Group 1 - The stock price of Microelectrophysiology fell by 5.03% to 24.57 CNY per share, with a trading volume of 203 million CNY and a turnover rate of 6.51%, resulting in a total market capitalization of 11.563 billion CNY [1] - Shanghai Microelectrophysiology Medical Technology Co., Ltd. was established on August 31, 2010, and went public on August 31, 2022. The company specializes in the research, development, production, and sales of innovative medical devices in the field of electrophysiological interventional diagnosis and ablation treatment [1] - The revenue composition of the company includes catheter products at 71.77%, other products at 20.22%, equipment products at 7.24%, and leasing services at 0.77% [1] Group 2 - According to data from the top ten holdings of funds, one fund under Penghua Fund holds shares in Microelectrophysiology. The Penghua Innovation Medicine Mixed A Fund (021308) held 148,700 shares in the fourth quarter, accounting for 7.17% of the fund's net value, ranking as the tenth largest holding [2] - The estimated floating loss for the fund today is approximately 193,300 CNY. The Penghua Innovation Medicine Mixed A Fund was established on May 28, 2024, with a latest scale of 35.9581 million CNY. Year-to-date return is 8.69%, ranking 2827 out of 9003 in its category; the one-year return is 39.24%, ranking 3383 out of 8185; and the return since inception is 30.01% [2] Group 3 - The fund managers of Penghua Innovation Medicine Mixed A Fund are Jin Xiaofei and Li Jianguo. As of the report, Jin Xiaofei has a cumulative tenure of 9 years and 219 days, with total fund assets of 5.331 billion CNY and the best fund return during his tenure being 258.74%, while the worst return is -0.92% [3] - Li Jianguo has a cumulative tenure of 220 days, with total fund assets of 47.9996 million CNY, achieving a best return of 5.09% and a worst return of 4.72% during his tenure [3]
微电生理股价跌5.03%,鹏华基金旗下1只基金重仓,持有14.87万股浮亏损失19.33万元